AMEDISYS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Other operating income
Net service revenue
Cost of service, inclusive of depreciation
General and administrative expenses:
Salaries and benefits
Non-cash compensation
Merger-related expenses
Depreciation and amortization
Impairment
Other
Total operating expenses
Operating income
Other income (expense):
Interest income
Interest expense
Equity in earnings (loss) from equity method investments
Merger termination fee
Gain on equity method investments
Miscellaneous, net
Total other expense, net
Income before income taxes
Income tax expense
Net income (loss)
Net loss attributable to noncontrolling interests
Net income (loss) attributable to Amedisys, Inc.
Basic earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders (usd per share)
Weighted average shares outstanding (shares)
Diluted earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders
Weighted average shares outstanding (shares)

Comments